Bank Of New York Mellon Corp Sqz Biotechnologies CO Transaction History

Bank Of New York Mellon Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $197,888 - $357,200	-71,440 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$4.01 - $10.42 $9,720 - $25,258	-2,424 Reduced 3.28%	71,440 $343,000
Q4 2021 Feb 11, 2022	BUY	$8.93 - $14.85 $41,703 - $69,349	4,670 Added 6.75%	73,864 $660,000
Q3 2021 Nov 12, 2021	BUY	$11.46 - $15.77 $93,754 - $129,014	8,181 Added 13.41%	69,194 $998,000
Q2 2021 Aug 11, 2021	BUY	$11.32 - $14.45 $541,005 - $690,594	47,792 Added 361.49%	61,013 $881,000
Q1 2021 May 13, 2021	SELL	$12.07 - $29.9 $14,496 - $35,909	-1,201 Reduced 8.33%	13,221 $180,000
Q4 2020 Feb 09, 2021	BUY	$13.25 - $34.58 $191,091 - $498,712	14,422 New	14,422 $417,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.